Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176,721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study.
Qian J, Wu Y, Li C, Yin J, Fu G, Wang J, He Y, Ma G, Chen Y, Xia Y, Li L, Ji F, Zeng H, Wei M, Nie S, Jin H, He B, Chen Y, Liu F, Wang H, Sun Y, Xu B, Ge J; PEPCAD China SVD study. Qian J, et al. Among authors: chen y. Catheter Cardiovasc Interv. 2023 Jan;101(1):33-43. doi: 10.1002/ccd.30472. Epub 2022 Dec 8. Catheter Cardiovasc Interv. 2023. PMID: 36480798 Clinical Trial.
Final kissing balloon inflation by classic crush stenting did not improve the clinical outcomes for the treatment of unprotected left main bifurcation lesions: the importance of double-kissing crush technique.
Chen S, Zhang J, Ye F, Chen Y, Fang W, Wei M, He B, Sun X, Yang S, Kwan TW. Chen S, et al. Among authors: chen y. Catheter Cardiovasc Interv. 2008 Feb 1;71(2):166-72. doi: 10.1002/ccd.21317. Catheter Cardiovasc Interv. 2008. PMID: 18231996 Clinical Trial.
[Comparison of DK crush with classical crush technique with drug-eluting stents for the treatment of coronary bifurcation lesions from DKCRUSH-1 study].
Chen SL, Zhang JJ, Ye F, Chen YD, Lü SZ, Tan H, Patel T, Kenji K, Tamari I, Shan SJ, Zhu ZS, Lin S, Tian NL, Li XB, Liu ZZ, Lee M, Wei M, Xu YW, Yuan ZB, Qian J, Sun XW, Yang S, Chen JG, He B, Sumit S. Chen SL, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Feb;36(2):100-7. Zhonghua Xin Xue Guan Bing Za Zhi. 2008. PMID: 19099943 Clinical Trial. Chinese.
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
Xu B, Dou KF, Han YL, Lü SZ, Yang YJ, Huo Y, Wang LF, Chen YD, Wang HC, Li WM, Chen JY, Wang L, Wang Y, Ge JB, Li W, Gao RL. Xu B, et al. Among authors: chen jy, chen yd. Chin Med J (Engl). 2011 Mar;124(6):811-6. Chin Med J (Engl). 2011. PMID: 21518585 Clinical Trial.
Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial.
Xu B, Dou K, Yang Y, Lv S, Wang L, Wang H, Li Z, Wang L, Chen Y, Huo Y, Li W, Kirtane AJ, Gao R. Xu B, et al. Among authors: chen y. EuroIntervention. 2012 Nov 22;8(7):796-802. doi: 10.4244/EIJV8I7A122. EuroIntervention. 2012. PMID: 23171800 Free article. Clinical Trial.
Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
Xu B, Qian J, Ge J, Wang J, Chen F, Chen J, Wei M, Chen Y, Yang Y, Gao R; PEPCAD China ISR investigators. Xu B, et al. Among authors: chen j, chen f, chen y. Catheter Cardiovasc Interv. 2016 Mar;87 Suppl 1:624-9. doi: 10.1002/ccd.26401. Epub 2016 Jan 17. Catheter Cardiovasc Interv. 2016. PMID: 26775079 Clinical Trial.
176,721 results
You have reached the last available page of results. Please see the User Guide for more information.